XSC
AVEO

X-Square Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

X-Square Capital’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-92,283
Closed -$759K – 159
2022
Q3 		$759K Hold
92,283
– – 0.48% 74
2022
Q2 		$606K Hold
92,283
– – 0.36% 82
2022
Q1 		$516K Hold
92,283
– – 0.27% 95
2021
Q4 		$433K Hold
92,283
– – 0.22% 110
2021
Q3 		$570K Sell
92,283
-8,550
-8% -$51.1K 0.29% 87
2021
Q2 		$665K Sell
100,833
-415
-0.4% -$2.86K 0.32% 81
2021
Q1 		$741K Buy
101,248
+25,296
+33% +$218K 0.34% 76
2020
Q4 		$438K Buy
75,952
+1,400
+2% +$8.02K 0.24% 81
2020
Q3 		$443K Buy
74,552
+8,644
+13% +$42.8K 0.32% 69
2020
Q2 		$339K Buy
65,908
+650
+1% +$4.1K 0.24% 67
2020
Q1 		$236K Sell
65,258
-3
-0% -$15 0.24% 62
2019
Q4 		$407K Hold
65,261
– – 0.24% 56
2019
Q3 		$551K Buy
+65,261
New +$486K 0.35% 44
2019
Q2 		– Sell
-27,068
Closed -$222K – 75
2019
Q1 		$222K Hold
27,068
– – 0.15% 63
2018
Q4 		$433K Sell
27,068
-1,375
-5% -$30.3K 0.34% 49
2018
Q3 		$942K Buy
28,443
+4,519
+19% +$116K 0.62% 39
2018
Q2 		$541K Buy
23,924
+781
+3% +$18.5K 0.41% 45
2018
Q1 		$671K Buy
23,143
+3,208
+16% +$93.9K 0.71% 36
2017
Q4 		$557K Buy
+19,935
New +$619K 0.59% 41

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

X-Square Capital's AVEO Position: Q4 2022 in Review

X-Square Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 92,283 shares — an estimated $759K sold.

X-Square Capital first reported a position in AVEO in Q4 2017 and held it in 19 quarters. The position peaked at $942K in Q3 2018. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • X-Square Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • X-Square Capital sold 92,283 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $759K.
  • X-Square Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 19 quarters.
  • X-Square Capital's AVEO Pharmaceuticals, Inc. position peaked at $942K in Q3 2018.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on X-Square Capital's 13F filing for Q4 2022, filed 2 Feb 2023.